Diamond-Konzept zur Behandlung von Pseudarthrosen und Knochendefekten-Reference-Cited by-同舟云学术

Diamond-Konzept zur Behandlung von Pseudarthrosen und Knochendefekten

Published:2020-08-06 Issue:9 Volume:123 Page:679-686
ISSN:0177-5537
Container-title:Der Unfallchirurg
language:de
Short-container-title:Unfallchirurg

Author:

Miska Matthias,Schmidmaier Gerhard

Publisher

Springer Science and Business Media LLC

Subject

Orthopedics and Sports Medicine,Emergency Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s00113-020-00843-1.pdf

Reference63 articles.

1. Andrzejowski P, Giannoudis PV (2019) The “diamond concept” for long bone non-union management. J Orthop Traumatol 20:21

2. Bigoni M, Turati M, Zanchi N et al (2019) Clinical applications of bioactive glass S53P4 in bone infections: a systematic review. Eur Rev Med Pharmacol Sci 23:240–251

3. Blokhuis TJ, Calori GM, Schmidmaier G (2013) Autograft versus BMPs for the treatment of non-unions: what is the evidence? Injury 44(1):S40–42

4. Bormann N, Pruss A, Schmidmaier G et al (2010) In vitro testing of the osteoinductive potential of different bony allograft preparations. Arch Orthop Trauma Surg 130:143–149

5. Bortolin M, De Vecchi E, Romano CL et al (2016) Antibiofilm agents against MDR bacterial strains: is bioactive glass BAG-S53P4 also effective? J Antimicrob Chemother 71:123–127

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modifizierte Masquelet-Technik zur Rekonstruktion kritischer Knochendefekte;Die Unfallchirurgie;2024-08-14

2. Modifizierte Masquelet-Plastik;Die Unfallchirurgie;2024-08-07

3. Reconstruction of an Extensive Segmental Radial Shaft Bone Defect by Vascularized 3D-Printed Graft Cage;Journal of Personalized Medicine;2024-02-04

4. Use of Autologous Bone Graft with Bioactive Glass as a Bone Substitute in the Treatment of Large-Sized Bone Defects of the Femur and Tibia;Journal of Personalized Medicine;2023-11-24

5. Effect of Tricalcium Phosphate on Healing of Non-Unions: An Observational Study of over 400 Non-Unions;Therapeutics and Clinical Risk Management;2023-05